![Soraya Bekkali](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Soraya Bekkali
Directeur/Bestuurslid bij
Vedere Bio II, Inc.
Profiel
Soraya Bekkali is currently a Director at Vedere Bio II, Inc. She was previously the President, Director & Head-R&D at Gyroscope Therapeutics Ltd., the Chief Medical Officer at Fovea Pharmaceuticals SA, and the Chief Medical Officer & Senior Vice President at Lysogene SA. Bekkali received an undergraduate degree from Sorbonne Université.
Actieve functies van Soraya Bekkali
| Bedrijven | Functie | Begin |
|---|---|---|
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Directeur/Bestuurslid | - |
Eerdere bekende functies van Soraya Bekkali
| Bedrijven | Functie | Einde |
|---|---|---|
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | President | 01-07-2019 |
| LYSOGENE | Hoofd Techniek/Wetenschap/O&O | - |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Soraya Bekkali
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Sorbonne Université
 Sorbonne Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Commercial Services |
